Stéphane Gerart is an engineer from the Ecole Polytechnique and the INA-PG and holds a PhD in immunology from Paris Descartes University. He begins his career as a business development consultant within the Consulting Firm Novoptim, a partner of choice in the strategic, marketing and operational support of fast-growing health life sciences companies on the European market. He then joins SOPHiA GENETICS in Canada. His mission as the country business development manager of this pioneer company in its field allowed him to acquire expertise in artificial intelligence and related applications. Back in France, as head of corporate business development for SOPHiA GENETICS, he is exposed to the booming ecosystem of new technologies in the healthcare world. He joins Oncodesign in 2020 to be responsible of the Artificial Intelligence Business Unit.